NYSE:CL • US1941621039
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COLGATE-PALMOLIVE CO (CL).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-03 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-02 | Deutsche Bank | Maintains | Hold -> Hold |
| 2026-02-02 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-02 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-02-02 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-02 | B of A Securities | Maintains | Buy -> Buy |
| 2026-02-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-02-02 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-02 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-02 | Jefferies | Maintains | Hold -> Hold |
| 2026-01-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-14 | UBS | Maintains | Buy -> Buy |
| 2026-01-13 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2026-01-08 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-07 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-12-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-11 | Argus Research | Downgrade | Buy -> Hold |
| 2025-12-09 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2025-11-04 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-03 | UBS | Maintains | Buy -> Buy |
| 2025-11-03 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-11-03 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-11-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-03 | Citigroup | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.457B 8.29% | 20.101B 3.31% | 20.382B 1.40% | 21.936B 7.62% | 22.661B 3.31% | 23.488B 3.65% | 23.944B 1.94% | 24.789B 3.53% | 25.319B 2.14% | 26.309B 3.91% | 27.336B 3.90% | |
| EBITDA YoY % growth | 4.585B 8.80% | 4.916B 7.22% | 4.956B 0.81% | 5.304B 7.02% | 5.546B 4.56% | 5.841B 5.32% | 6.081B 4.11% | 6.346B 4.36% | 6.848B 7.91% | 7.17B 4.70% | 7.504B 4.66% | |
| EBIT YoY % growth | 4.018B 9.51% | 4.311B 7.29% | 4.326B 0.35% | 4.645B 7.37% | 4.873B 4.91% | 5.144B 5.56% | 5.389B 4.76% | 5.64B 4.66% | 6.049B 7.25% | 6.341B 4.83% | 6.645B 4.79% | |
| Operating Margin | 20.65% | 21.45% | 21.22% | 21.18% | 21.50% | 21.90% | 22.51% | 22.75% | 23.89% | 24.10% | 24.31% | |
| EPS YoY % growth | 3.23 8.75% | 3.59 11.15% | 3.69 2.79% | 3.99 8.16% | 4.26 6.84% | 4.57 7.13% | 4.85 6.11% | 5.15 6.25% | 5.74 11.41% | 6.15 7.18% | 6.59 7.20% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.97 7.07% | 1.00 8.42% | 0.98 7.96% | 1.00 4.95% | 1.04 6.72% | 1.06 6.72% | 1.04 6.29% | 1.06 6.28% |
| Revenue Q2Q % growth | 5.364B 9.22% | 5.492B 7.48% | 5.438B 5.98% | 5.428B 3.79% | 5.495B 2.44% | 5.62B 2.33% | 5.627B 3.48% | 5.615B 3.45% |
| EBITDA Q2Q % growth | 1.304B 5.25% | 1.324B -4.61% | 1.307B -13.79% | 1.319B -24.11% | 1.358B 4.14% | 1.389B 4.91% | 1.353B 3.52% | 1.376B 4.32% |
| EBIT Q2Q % growth | 1.145B 4.95% | 1.158B 6.34% | 1.148B 8.40% | 1.162B 4.87% | 1.2B 4.80% | 1.228B 6.04% | 1.203B 4.79% | 1.225B 5.42% |
All data in USD
30 analysts have analysed CL and the average price target is 97.5 USD. This implies a price increase of 14.03% is expected in the next year compared to the current price of 85.5.
COLGATE-PALMOLIVE CO (CL) will report earnings on 2026-05-01, before the market open.
The consensus EPS estimate for the next earnings of COLGATE-PALMOLIVE CO (CL) is 0.97 USD and the consensus revenue estimate is 5.36B USD.
The number of analysts covering COLGATE-PALMOLIVE CO (CL) is 30.